Not your typical strongyloides infection: A literature review and case study

Southern Medical Journal

Volumn 99, Issue 8, 2006, Pages 847-852

  Foreman, Elizabeth B ^a   Abraham, Philip J ^a   Garland, Jeffrey L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hyperinfection syndrome; Pneumocystis jiroveci; Pneumonia; Strongyloidiasis

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; IVERMECTIN; MEBENDAZOLE; TIABENDAZOLE;

AGED; ANOREXIA; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DIZZINESS; ENDEMIC DISEASE; FATIGUE; HUMAN; IMMUNE DEFICIENCY; LIVER DISEASE; MALE; MORTALITY; NAUSEA; PATHOGENESIS; PNEUMOCYSTIS JIROVECI; PNEUMONIA; RESPIRATORY FAILURE; REVIEW; STRONGYLOIDES; STRONGYLOIDIASIS;

AGED; ANIMALS; ANTIPARASITIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; MALE; PNEUMONIA, PNEUMOCYSTIS; STRONGYLOIDES; STRONGYLOIDIASIS;

EID: 33747188357     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000203813.70054.3c     Document Type: Review

References (21)

1. Igra-Siegman Y, Kapila R, Sen P, et al. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981;3:397-407.
2. Longworth DL, Weller PF. Hyperinfection syndrome with strongyloidiasis. Curr Clin Top Infect Dis 1986;7:1-26.
3. Scowden EB, Schaffner W, Stone WJ. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 1978;57:527-44.
4. Zaha O, Hirata T, Kinjo F, et al. Strongyloidiasis: progress in diagnosis and treatment. Intern Med 2000;39:695-700.
5. Nagaraj P, Czachor JS, Hawley B. Strongyloides hyperinfection with pulmonary hemorrhage and ARDS. Infect Med 2000;17:208-12.
6. Boyd WP, Jr. Campbell FW, Trudeau WL. Strongyloides stercoralis - hyperinfection. Am J Trop Med Hyg 1978;27(Pt 1):39-41.
7. Wehner JH, Kirsch CM. Pulmonary manifestations of strongyloidiasis. Semin Respir Infect 1997;12:122-129.
8. Upadhyay D, Corbridge T, Jain M, et al. Pulmonary hyperinfection syndrome with Strongyloides stercoralis. Am J Med 2001;111:167-169.
9. Rivera E, Maldonado N, Velez-Garcia E, et al. Hyperinfection syndrome with Strongyloides stercoralis. Ann Intern Med 1970;72:199-204.
10. Rogers WA, Jr. Nelson B. Strongyloidiasis and malignant lymphoma: "Opportunistic infection" by a nematode. JAMA 1966;195:685-687.
11. Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 1966;275:1093-1096.
12. Cook GA, Rodriguez H, Silva H, et al. Adult respiratory distress secondary to strongyloidiasis. Chest 1987;92:1115-1116.
13. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 20011;33:1040-1047.
14. Sanchez PR, Guzman AP, Guillen SM, et al. Endemic strongyloidiasis on the Spanish Mediterranean coast. QJM 2001;94:357-363.
15. Nonaka D, Takaki K, Tanaka M, et al. Paralytic ileus due to strongyloidiasis: case report and review of the literature. Am J Trop Med Hyg 1998;59:535-538.
16. Loutfy MR, Wilson M, Keystone JS, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a nonendemic area. Am J Trop Med Hyg 2002;66:749-752.
17. Lindo JF, Atkins NS, Lee MG, et al. Short report: long-term serum antibody isotype responses to Strongyloides stercoralis filariform antigens in eight patients treated with ivermectin. Am J Trop Med Hyg 1996;55:474-476.
18. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121(Suppl):S113-S132.
19. Wong TY, Szeto CC, Lai FF, et al. Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents. Nephron 1998;79:333-336.
20. Dreyfuss ML, Msamanga GI, Spiegelman D, et al. Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr 2001;74:814-826.
21. Adedayo AO, Grell GA, Bellot P. Case study: fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2001;65:650-651.